Venlafaxine-associated nocturnal bruxism in a depressive patient successfully treated with buspirone

Kuloğlu, Mehmet Murat; Ekinci, Okan; Çayköylü, Ali

doi:10.1177/0269881109102612

Cited by 31 publications

(13 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…It probably acts as an SSRI at low doses (5). In the present case, venlafaxine was used at a dose of 75 mg/day which makes it possible to act as an SSRI.…”

Section: Discussionmentioning

confidence: 83%

Venlafaksinin Neden Olduğu Huzursuz Bacak Sendromu / Venlafaxine-İnduced Restless Legs Syndrome

Milanlıoğlu¹

2012

Dusunen Adam

View full text Add to dashboard Cite

Venlafaxine-induced restless legs syndromeRestless legs syndrome is a movement disorder characterized by complaints of a strong urge to move the legs predominantly during the periods of rest or inactivity. It is obsen/ed as a side efFect related to the administration of antidepressants in 9% of patients. A case reporting restless legs syndrome symptoms associated with venlafaxine 75 mg/day is decribed. The patient was a M-year-old woman affected by chronic migraine headaches with depressive symptoms. Her symptoms had began during a course of venlafaxine and resolved with its discontinuation. Based on this report, venlafaxine should be added to the list of agents that can induce restless 'egs syndrome. ÖZET Venlafaksinin neden oldugu huzursuz bacak sendromuHuzursuz bacak sendromu; dinlenme veya hareketsizük dönemlerinde daha belirgin olarak ortaya çkan, bacaklan hareket ettirme yônùnde gûçlû bir ihtiyaç ile karakterize hareket bozuklugudur. Huzursuz bacak sendromu, antidepresan kulianan hastalann %9'unda ilaç kullanimiyla ili^kili bir yan etki olarak kaydedilmiçdr. Depresif semptomlan da olan A4 yaçindaki kronik migrenii bir kadin hastada, 75 mg/gùn venlafaksin kulianimi ile ortaya çikan bir huzursuz bacak sendromu tablosu sunulmaktadir. Semptomlar venlafaksin ile baçlamiç ve ilacin kesilmesi ile dùzelmiçtir. Bu vaka temelinde, venlafaksinin huzursuz bacak sendromuna neden olabilecek ilaçlar listesine eklenmesi gerektigi dûçûnûlmektedir. Anahtar kelimeler Antidepresanlar, huzursuz bacak sendromu, venlafaksin, serotonin-norepinefrin gerialim inhibitorieri

show abstract

“…It probably acts as an SSRI at low doses (5). In the present case, venlafaxine was used at a dose of 75 mg/day which makes it possible to act as an SSRI.…”

Section: Discussionmentioning

confidence: 83%

Venlafaksinin Neden Olduğu Huzursuz Bacak Sendromu / Venlafaxine-İnduced Restless Legs Syndrome

Milanlıoğlu¹

2012

Dusunen Adam

View full text Add to dashboard Cite

show abstract

“…[ 8 ] Indeed, venlafaxine induced nocturnal bruxism has been reported previously. [ 9 10 11 ] This adverse effect had a temporal relationship with initiating venlafaxine and it remitted on stopping this drug in our patient. It did not reoccur on substituting it with escitalopram, which has a very selective action on serotonin.…”

mentioning

confidence: 72%

Venlafaxine-Induced Severe Sleep Bruxism in a Patient with Generalized Anxiety Disorder

Jose¹

2015

Indian Journal of Psychological Medicine

View full text Add to dashboard Cite

“…If the problem persists, a reduction of dose or change of medication may alleviate or even resolve the problem [ 57 – 59 , 73 , 79 ], although a definitive cease might be expected with drug withdrawal [ 58 , 63 , 66 , 72 , 74 , 75 , 79 , 81 ]. In those cases in which the psychiatric symptoms have been successfully improved with the current medication and no changes are planned, some authors have co-prescribed buspirone [ 57 , 64 , 71 , 72 , 75 , 76 ], tandospirone [ 68 ], or gabapentine [ 65 , 69 , 77 ], reporting a complete cease of bruxism. However, caution mast be taking with the generalization of these findings, since case reports cannot establish cause-effect relationships and are susceptible to publication bias and over-interpretation.…”

Section: Bruxism As An Adverse Effect Of Medicationsmentioning

confidence: 99%

Current Treatments of Bruxism

Guaita

Högl

2016

Curr Treat Options Neurol

View full text Add to dashboard Cite

Opinion statementDespite numerous case reports, the evidence for treatment of bruxism is still low. Different treatment modalities (behavioral techniques, intraoral devices, medications, and contingent electrical stimulation) have been applied. A clinical evaluation is needed to differentiate between awake bruxism and sleep bruxism and rule out any medical disorder or medication that could be behind its appearance (secondary bruxism). A polysomnography is required only in a few cases of sleep bruxism, mostly when sleep comorbidities are present. Counselling with regard to sleep hygiene, sleep habit modification, and relaxation techniques has been suggested as the first step in the therapeutic intervention, and is generally considered not harmful, despite low evidence of any efficacy. Occlusal splints are successful in the prevention of dental damage and grinding sounds associated with sleep bruxism, but their effects on reducing bruxism electromyographic (EMG) events are transient. In patients with psychiatric and sleep comorbidities, the acute use of clonazepam at night has been reported to improve sleep bruxism, but in the absence of double-blind randomized trials, its use in general clinical practice cannot be recommended. Severe secondary bruxism interfering with speaking, chewing, or swallowing has been reported in patients with neurological disorders such as in cranial dystonia; in these patients, injections of botulinum toxin in the masticatory muscles may decrease bruxism for up to 1–5 months and improve pain and mandibular functions. Long-term studies in larger and better specified samples of patients with bruxism, comparing the effects of different therapeutic modalities on bruxism EMG activity, progression of dental wear, and orofacial pain are current gaps of knowledge and preclude the development of severity-based treatment guidelines.

show abstract

Venlafaxine-associated nocturnal bruxism in a depressive patient successfully treated with buspirone

Cited by 31 publications

References 13 publications

Venlafaksinin Neden Olduğu Huzursuz Bacak Sendromu / Venlafaxine-İnduced Restless Legs Syndrome

Venlafaksinin Neden Olduğu Huzursuz Bacak Sendromu / Venlafaxine-İnduced Restless Legs Syndrome

Venlafaxine-Induced Severe Sleep Bruxism in a Patient with Generalized Anxiety Disorder

Current Treatments of Bruxism

Contact Info

Product

Resources

About